SCHEDULE: American Century Discloses 5.5% Stake in Kennametal

Sentiment:

Beneficial Ownership Report


American Century Investment Management, Inc., along with its parent entities, has reported a 5.5% beneficial ownership stake in Kennametal Inc. as of September 30, 2025.

Summary

  • American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research collectively beneficially own 4,221,461 shares of Kennametal Inc. Capital Stock.
  • This ownership represents 5.5% of Kennametal Inc.'s outstanding Capital Stock.
  • The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Kennametal Inc.
  • American Century Investment Management, Inc. holds sole voting power over 4,180,805 shares and sole dispositive power over 4,221,461 shares.
  • The filing was made under Rule 13d-1(b), indicating the reporting persons are institutional investors.

Sentiment

Score: 6

Explanation: The filing indicates a significant, passive ownership stake by a reputable investment management firm, which is generally a neutral to slightly positive signal for the issuer, reflecting institutional confidence without implying active engagement or strategic changes.

Positives

  • A significant institutional investor, American Century Investment Management, Inc., holds a substantial stake, potentially indicating confidence in Kennametal Inc.'s long-term prospects.
  • The filing explicitly states the shares are held in the ordinary course of business and not for control-influencing purposes, suggesting a passive investment approach.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • American Century Investment Management, Inc. (ACIM) is a wholly-owned subsidiary of American Century Companies, Inc. (ACC).
  • American Century Companies, Inc. (ACC) is controlled by the Stowers Institute for Medical Research.
  • These entities are filing jointly due to their control relationships regarding the beneficial ownership of Kennametal Inc. shares.

Stakeholder Impact

  • Shareholders: Disclosure of a significant institutional investor holding 5.5% of the company's capital stock provides transparency regarding the ownership structure and may influence market perception.

Key Dates

DateDescription
09/30/2025Date of event requiring the filing of this statement, indicating the beneficial ownership position.
11/14/2025Date of signing and joint filing agreement for the Schedule 13G.

Keywords

Kennametal Inc., American Century Investment Management, Beneficial Ownership, Schedule 13G, Institutional Investor, Capital Stock, Investment Management, Stowers Institute for Medical Research

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.